Gov't expands MediShield Life to cover precision medicine therapies

The high-scot therapies can be rough into ediShield Life and MediSave, amongst others

Precision medicine therapies will soon be included in MediShield Life coverage, Health Minister Ong Ye Kung revealed.

In his speech at the Singapore Health & Biomedical Congress 2024, Ong said the health ministry intended to accept the MediShield Life Council's recommendation to include precision medicine therapies in its coverage.

"The approved precision medicine therapies or high-cost therapies can be brought into our subsidy, MediShield Life and MediSave, or S+2M, support framework, and all Singaporeans can benefit from these therapies," Ong said.

Ong said there is no healthcare financing system in the world designed to fully fund precision medicine, making it affordable only for the wealthy, which could eventually lead to serious inequity in healthcare.

Singapore is taking steps to embrace precision medicine and prepare for its mainstream adoption sustainably, said Ong.

"We have strengthened health technology assessment to robustly evaluate the cost-effectiveness of high-cost treatments, including precision medicine," Ong said.

"Even if the medicine increases the chance of a treatment that can prolong quality life but costs so much more, we can conclude that it is not cost-effective. Where they are proven to be clinically and cost effective, we will subsidise these therapies," Ong added.

Follow the link for more news on

Ministry of Health

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia